Evidence mapPaperPMID 37732829Full record

ReviewPhysiological reviews2024

Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries.

Genesee J Martinez, Malik Appleton, Zachary A Kipp, Analia S Loria, Booki Min, Terry D Hinds

Open access · greenAbstract readReview
In one paragraph

Review in Physiological reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
21.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Glucose as a Biomarker for Stress in Firefighters.Journal of occupational and environmental medicine · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Genesee J MartinezDepartment of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, Kentucky, United States.ORCID 0000-0002-4593-7708
Malik AppletonDepartment of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, Kentucky, United States.
Zachary A KippDepartment of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, Kentucky, United States.ORCID 0000-0001-7344-7469
Analia S LoriaDepartment of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, Kentucky, United States.ORCID 0000-0002-9284-2146
Booki MinDepartment of Microbiology and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States.
Terry D HindsDepartment of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, Kentucky, United States.ORCID 0000-0002-7599-1529
University of Kentucky · USNorthwestern University · US

Funding

University of Kentucky Markey Cancer Center – Cancer Center Support GrantP30CA177558 · UNIVERSITY OF KENTUCKY · 2025 to 2025
$2.8M
Neurobehavioral mechanisms underlying xylazine and fentanyl co-use and withdrawalR01DA058933 · UNIVERSITY OF KENTUCKY · 2025 to 2025
$497k
The role of IL-27/Lag3 axis in regulating Foxp3+ regulatory T cell functionR01AI125247 · NORTHWESTERN UNIVERSITY · 2025 to 2025
$456k
Effect of early life stress on obesity-induced hypertension in miceR01HL135158 · NHLBI · UNIVERSITY OF KENTUCKY · PI Analia Loria · 2022 to 2022
$383k
miR-342, a novel glucocorticoid-responsive miRNA necessary for Foxp3+ regulatory T cell functionR21AI172135 · NIAID · NORTHWESTERN UNIVERSITY · PI Booki Min · 2024 to 2024
$240k
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic DysfunctionF31HL170972 · UNIVERSITY OF KENTUCKY · 2025 to 2025
$36k
NCI NIH HHS P30 CA177558NHLBI NIH HHS F31 HL170972NHLBI NIH HHS R01 HL135158NHLBI NIH HHS R01 HL142969NIAID NIH HHS R01 AI125247NIAID NIH HHS R01 AI147498NIAID NIH HHS R21 AI172135NIDA NIH HHS R01 DA058933NIDDK NIH HHS R01 DK121797NIMHD NIH HHS L32 MD009154NIMHD NIH HHS L32 MD011984
6 · The paper itself

Abstract

The normal stress response in humans is governed by the hypothalamic-pituitary-adrenal (HPA) axis through heightened mechanisms during stress, raising blood levels of the glucocorticoid hormone cortisol. Glucocorticoids are quintessential compounds that balance the proper functioning of numerous systems in the mammalian body. They are also generated synthetically and are the preeminent therapy for inflammatory diseases. They act by binding to the nuclear receptor transcription factor glucocorticoid receptor (GR), which has two main isoforms (GRα and GRβ). Our classical understanding of glucocorticoid signaling is from the GRα isoform, which binds the hormone, whereas GRβ has no known ligands. With glucocorticoids being involved in many physiological and cellular processes, even small disruptions in their release via the HPA axis, or changes in GR isoform expression, can have dire ramifications on health. Long-term chronic glucocorticoid therapy can lead to a glucocorticoid-resistant state, and we deliberate how this impacts disease treatment. Chronic glucocorticoid treatment can lead to noticeable side effects such as weight gain, adiposity, diabetes, and others that we discuss in detail. There are sexually dimorphic responses to glucocorticoids, and women tend to have a more hyperresponsive HPA axis than men. This review summarizes our understanding of glucocorticoids and critically analyzes the GR isoforms and their beneficial and deleterious mechanisms and the sexual differences that cause a dichotomy in responses. We also discuss the future of glucocorticoid therapy and propose a new concept of dual GR isoform agonist and postulate why activating both isoforms may prevent glucocorticoid resistance.

Indexed as

GlucocorticoidsHypothalamo-Hypophyseal SystemAnimalsFemaleHumansMaleMammalsPituitary-Adrenal SystemProtein IsoformsReceptors, GlucocorticoidSex CharacteristicsGlucocorticoidsProtein IsoformsReceptors, Glucocorticoid11β-HSD1dual GR agonistglucocorticoid resistanceHPA axisinflammation

Identifiers

PMID37732829
PMCPMC11281820
OpenAlexW4386910018

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.